Table 175
Percent of patients with adverse drug events: anticoagulant-related warfarin, United States, 2005a |
Population group |
Percent |
SE |
Total |
|
6.89 |
0.41 |
Age |
Under 65 |
6.58 |
1.30 |
65-74 |
7.28 |
0.75 |
75-84 |
6.64 |
0.62 |
85 and over |
6.97 |
0.99 |
Gender |
Female |
6.98 |
0.55 |
Male |
6.77 |
0.61 |
Race |
White |
6.92 |
0.43 |
Black |
6.64 |
1.56 |
Other |
* |
* |
Diabetes |
Yes |
7.21 |
0.74 |
No |
6.74 |
0.49 |
Obesity |
Yes |
8.51 |
1.27 |
No |
6.66 |
0.43 |
Cerebrovascular disease |
Yes |
7.97 |
0.84 |
No |
6.49 |
0.46 |
CHF/pulmonary edema |
Yes |
7.55 |
0.66 |
No |
6.41 |
0.52 |
COPD |
Yes |
7.77 |
0.77 |
No |
6.48 |
0.48 |
Smoking |
Yes |
6.79 |
1.29 |
No |
6.90 |
0.43 |
Corticosteroids |
Yes |
10.86 |
1.66 |
No |
6.49 |
0.42 |
Coronary artery disease |
Yes |
6.75 |
0.58 |
No |
7.01 |
0.57 |
Renal disease |
Yes |
11.31 |
1.00 |
No |
5.32 |
0.42 |
a Data include Medicare beneficiaries discharged from January to December.
* Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.